跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
维建乐 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Ombitasvir,Paritaprevir and Ritonavir Tablets
Approved
化学药品
Ombitasvir,Paritaprevir and Ritonavir Tablets
FOURNIER LABORATORIES IRELAND LIMITED
🇨🇳 National Medical Products Administration
Approval Date
Mar 2, 2018
Approval ID
7MaoUKatZol
Company
FOURNIER LABORATORIES IRELAND LIMITED
Type
化学药品
Approval Details
Approval Id
7MaoUKatZol
Approval Number
H20181131
Generic Name
奥比帕利片
Generic Name En
Ombitasvir,Paritaprevir and Ritonavir Tablets
Trade Name
维建乐
Drug Type
化学药品
Dosage Form
片剂
Reg Date
2018-03-02
Expired Date
2022-09-19
Company Name
FOURNIER LABORATORIES IRELAND LIMITED
Company Address
Maidenhead SL6 4UB,United Kingdom
Production Company Name
FOURNIER LABORATORIES IRELAND LIMITED
Production Company Address
Anngrove, Carrigtwohill, Co. Cork, Ireland
Company Detail Path
/organization/fournier-laboratories-ireland-limited
Production Company Detail Path
/organization/fournier-laboratories-ireland-limited
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Mar 2, 2018
Approval ID
7MaoUKatZol
Type
化学药品
Back to NMPA Approvals